Discontinued Cardiovascular and Metabolic Drug Database

The database records the following features of discontinued drugs for cardiovascular and metabolic diseases within the 2011-2021 time-window: ● drug name ● sponsor company ● genetic target (N/A for those that are unclear or involves analog/replacement) ● target name (usually a protein) and acronyms ● indications ● highest stage when the drug was discontinued ● year of discontinuation ● reason for discontinuation (if there is any) ● source of information ● new indications, new name, the highest stage of repurposing and the company that repurposed the drug.